Institutional Sign In

Go

Shop Apotheke Europe

Shop Apotheke Europe's net profit rose 15.6% yoy to EUR -62.6 mil in 2022

By Helgi Library - May 22, 2023

Shop Apotheke Europe made a net profit of EUR -62.6 mil with revenues of EUR 1,229 mil in 2022, up by 15.6% and up by 1...

Shop Apotheke Europe's net profit rose 15.6% yoy to EUR -62.6 mil in 2022

By Helgi Library - May 22, 2023

Shop Apotheke Europe made a net profit of EUR -62.6 mil with revenues of EUR 1,229 mil in 2022, up by 15.6% and up by 1...

Shop Apotheke Europe's price/earnings (P/E) rose 55.9% yoy to -12.0 in 2022

By Helgi Library - May 22, 2023

Shop Apotheke Europe stock traded at EUR 41.8 per share at the end 2022 translating into a market capitalization of USD 885 mil. ...

Profit Statement 2028 2029 2030
Sales EUR mil 3,461 3,775 4,098
Gross Profit EUR mil 920 1,004 1,090
EBITDA EUR mil 207 249 275
EBIT EUR mil 181 211 243
Financing Cost EUR mil 33.8 37.0 42.5
Pre-Tax Profit EUR mil 147 174 200
Net Profit EUR mil 113 136 152
Dividends EUR mil 0 0 0
Balance Sheet 2028 2029 2030
Total Assets EUR mil 1,437 1,545 1,662
Non-Current Assets EUR mil 770 846 930
Current Assets EUR mil 666 699 732
Working Capital EUR mil 104 113 123
Shareholders' Equity EUR mil 649 784 936
Liabilities EUR mil 788 761 726
Total Debt EUR mil 513 461 402
Net Debt EUR mil 210 158 97.4
Ratios 2028 2029 2030
ROE % 19.0 18.9 17.7
ROCE % 13.5 14.8 15.1
Gross Margin % 26.6 26.6 26.6
EBITDA Margin % 5.99 6.60 6.72
EBIT Margin % 5.22 5.58 5.92
Net Margin % 3.25 3.60 3.71
Net Debt/EBITDA 1.01 0.635 0.354
Net Debt/Equity % 32.4 20.2 10.4
Cost of Financing % 6.37 7.60 9.85
Valuation 2028 2029 2030
Market Capitalisation USD mil 1,947 1,947 1,947
Enterprise Value (EV) USD mil 2,194 2,132 2,061
Number Of Shares mil 18.1 18.1 18.1
Share Price EUR 91.9 91.9 91.9
EV/EBITDA 9.02 7.30 6.38
EV/Sales 0.540 0.482 0.429
Price/Earnings (P/E) 14.7 12.2 10.9
Price/Book Value (P/BV) 2.56 2.12 1.77
Dividend Yield % 0 0 0

Get all company financials in excel:

Download Sample   $19.99

overview Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
income statement                                            
Sales EUR mil ... ... ... ...         284 540 701 968 1,060                  
Gross Profit EUR mil ... ... ... ...         57.6 99.3 138 220 267                  
EBIT EUR mil ... ... ... ...         -19.2 -28.7 -33.4 -0.866 -65.7                  
Net Profit EUR mil ... ... ... ...         -21.4 -33.6 -36.3 -16.8 -74.2                  
                                               
ROE % ... ... ... ... ...       -12.9 -14.8 -16.2 -5.10 -17.7                  
EBIT Margin % ... ... ... ...         -6.76 -5.32 -4.77 -0.089 -6.20                  
Net Margin % ... ... ... ...         -7.52 -6.23 -5.17 -1.73 -7.00                  
Employees ... ... ... ...         483 843 1,011 1,220 1,569 ... ... ... ... ... ... ... ... ...
balance sheet                                            
Total Assets EUR mil ... ... ... ...         298 350 428 537 783                  
Non-Current Assets EUR mil ... ... ... ...         202 214 217 283 350                  
Current Assets EUR mil ... ... ... ...         95.4 136 211 254 433                  
                                               
Shareholders' Equity EUR mil ... ... ... ...         239 214 233 425 415                  
Liabilities EUR mil ... ... ... ...         58.8 136 195 112 368                  
Non-Current Liabilities EUR mil                 17.4 83.3 135 37.2 244                  
Current Liabilities EUR mil ... ... ... ...         41.5 52.7 59.8 74.6 124                  
                                               
Net Debt/EBITDA ... ... ... ...         1.93 -1.92 -1.94 -5.92 1.22                  
Net Debt/Equity % ... ... ... ...         -9.80 14.0 15.5 -21.2 -11.4                  
Cost of Financing % ... ... ... ... ... ... ... ... 90.5 13.3 8.55 11.5 6.24                  
cash flow                                            
Total Cash From Operations EUR mil ... ... ... ...         -25.3 -18.2 -36.4 4.88 5.29                  
Total Cash From Investing EUR mil ... ... ... ...         -0.858 -38.6 -33.4 -40.3 -84.3                  
Total Cash From Financing EUR mil ... ... ... ...         -1.42 70.2 108 63.2 236                  
Net Change In Cash EUR mil ... ... ... ...         -27.6 13.4 38.3 27.8 157                  
valuation                                            
Market Capitalisation USD mil ... ... ... ... ... ... ...   670 519 638 3,203 2,304                  
Enterprise Value (EV) USD mil ... ... ... ... ... ... ...   642 553 678 3,093 2,250                  
Number Of Shares mil ... ... ... ... ... ... ...   9.50 12.0 13.1 14.4 17.9                  
Share Price EUR ... ... ... ... ... ... ...   46.4 37.6 43.5 148 113                  
Price/Earnings (P/E) ... ... ... ... ... ... ...   -20.6 -13.5 -15.6 -127 -27.3                  
Price/Cash Earnings (P/CE) ... ... ... ... ... ... ...   -23.3 -15.1 -26.5 -195 -32.3                  
EV/EBITDA ... ... ... ... ... ... ...   -47.1 -30.3 -32.2 174 -48.5                  
Price/Book Value (P/BV) ... ... ... ... ... ... ...   1.84 2.12 2.44 5.01 4.88                  
Dividend Yield % ... ... ... ... ... ... ...   0 0 0 0 0                  
income statement Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
income statement                                            
Sales EUR mil ... ... ... ...         284 540 701 968 1,060                  
Cost of Goods & Services EUR mil ... ... ... ...         226 440 563 749 794                  
Gross Profit EUR mil ... ... ... ...         57.6 99.3 138 220 267                  
Selling, General & Admin EUR mil ... ... ... ...         79.8 128 172 204 305 ... ... ... ... ... ... ... ... ...
Research & Development EUR mil ... ... ... ...         0 0 0 0 0 ... ... ... ... ... ... ... ... ...
Other Operating Expense EUR mil ... ... ... ... ... ... ...   0.002 0.002 0.001 0 0 ... ... ... ... ... ... ... ... ...
Staff Cost EUR mil ... ... ... ...         20.0 40.0 54.1 66.9 120 ... ... ... ... ... ... ... ... ...
Other Operating Cost (Income) EUR mil ... ... ... ...         3.02 0.196 0.736 0.065 0.160 ... ... ... ... ... ... ... ... ...
EBITDA EUR mil ... ... ... ...         -12.1 -15.6 -18.6 15.2 -38.7                  
Depreciation EUR mil ... ... ... ...         2.49 3.62 14.9 5.82 11.4                  
EBIT EUR mil ... ... ... ...         -19.2 -28.7 -33.4 -0.866 -65.7                  
Net Financing Cost EUR mil ... ... ... ... ... ... ... ... 2.20 5.90 8.84 10.8 8.57                  
Financing Cost EUR mil ... ... ... ... ... ... ... ... 2.20 6.20 10.2 10.8 8.57                  
Financing Income EUR mil ... ... ... ... ... ... ... ... 0 0.300 1.33 0 0                  
FX (Gain) Loss EUR mil ... ... ... ... ... ... ...   0 0 0 0.234 -1.49                  
(Income) / Loss from Affiliates EUR mil ... ... ... ... ... ... ... ... ... ... -0.104 -0.045 0.427                  
Extraordinary Cost EUR mil ... ... ... ...         0 0 0 0 0                  
Pre-Tax Profit EUR mil ... ... ... ...         -21.4 -34.6 -42.2 -15.9 -77.9                  
Tax EUR mil ... ... ... ...         -0.045 -0.982 -5.91 0.839 -3.70                  
Minorities EUR mil ... ... ... ...         0 0 0 0 0                  
Net Profit EUR mil ... ... ... ...         -21.4 -33.6 -36.3 -16.8 -74.2                  
Net Profit Avail. to Common EUR mil ... ... ... ...         -21.4 -33.6 -36.3 -16.8 -74.2                  
Dividends EUR mil ... ... ... ... ... ... ...   0 0 0 0 0                  
growth rates                                            
Total Revenue Growth % ... ... ... ... ...       60.1 90.0 29.9 38.1 9.53                  
Operating Cost Growth % ... ... ... ... ...       59.2 60.7 34.0 28.3 50.8 ... ... ... ... ... ... ... ... ...
Staff Cost Growth % ... ... ... ... ...       47.6 99.9 35.3 23.8 78.8 ... ... ... ... ... ... ... ... ...
EBITDA Growth % ... ... ... ... ...       45.1 28.2 19.4 -182 -355                  
EBIT Growth % ... ... ... ... ...       64.9 49.7 16.4 -97.4 7,486                  
Pre-Tax Profit Growth % ... ... ... ... ...       2.11 61.6 21.9 -62.2 389                  
Net Profit Growth % ... ... ... ... ...       15.8 57.4 7.92 -53.8 342                  
ratios                                            
ROE % ... ... ... ... ...       -12.9 -14.8 -16.2 -5.10 -17.7                  
ROA % ... ... ... ... ...       -10.2 -10.4 -9.33 -3.48 -11.2                  
ROCE % ... ... ... ... ...       -15.3 -13.6 -13.9 -5.48 -20.1                  
Gross Margin % ... ... ... ...         20.3 18.4 19.6 22.7 25.1                  
EBITDA Margin % ... ... ... ...         -4.27 -2.88 -2.65 1.57 -3.65                  
EBIT Margin % ... ... ... ...         -6.76 -5.32 -4.77 -0.089 -6.20                  
Net Margin % ... ... ... ...         -7.52 -6.23 -5.17 -1.73 -7.00                  
Payout Ratio % ... ... ... ... ... ... ...   0 0 0 0 0                  
Cost of Financing % ... ... ... ... ... ... ... ... 90.5 13.3 8.55 11.5 6.24                  
Net Debt/EBITDA ... ... ... ...         1.93 -1.92 -1.94 -5.92 1.22                  
balance sheet Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
balance sheet                                            
Cash & Cash Equivalents EUR mil ... ... ... ... ... ... ...   28.3 58.8 113 128 284                  
Receivables EUR mil ... ... ... ...         20.5 22.1 26.7 30.0 27.9                  
Inventories EUR mil ... ... ... ...         40.0 43.3 56.7 81.2 96.6                  
Other ST Assets EUR mil ... ... ... ...         6.52 11.5 14.2 14.6 24.4                  
Current Assets EUR mil ... ... ... ...         95.4 136 211 254 433                  
Property, Plant & Equipment EUR mil ... ... ... ...         8.28 11.9 13.2 74.5 78.3                  
LT Investments & Receivables EUR mil ... ... ... ...         0 0 2.50 1.74 13.1                  
Intangible Assets EUR mil ... ... ... ...         190 200 200 205 257                  
Goodwill EUR mil ... ... ... ...         126 129 129 129 153                  
Non-Current Assets EUR mil ... ... ... ...         202 214 217 283 350                  
Total Assets EUR mil ... ... ... ...         298 350 428 537 783                  
                                               
Trade Payables EUR mil ... ... ... ...         23.1 26.1 31.4 51.3 78.1                  
Short-Term Debt EUR mil ... ... ... ...         4.86 16.3 17.7 5.42 6.41                  
Other ST Liabilities EUR mil ... ... ... ...         7.31 7.93 10.1 8.32 15.1                  
Current Liabilities EUR mil ... ... ... ...         41.5 52.7 59.8 74.6 124                  
Long-Term Debt EUR mil ... ... ... ...         0 72.4 132 32.8 230                  
Other LT Liabilities EUR mil ... ... ... ...         17.4 10.8 3.90 4.35 13.6                  
Non-Current Liabilities EUR mil                 17.4 83.3 135 37.2 244                  
Liabilities EUR mil ... ... ... ...         58.8 136 195 112 368                  
Preferred Equity and Hybrid Capital EUR mil ... ... ... ...         0 0 0 0 0                  
Share Capital EUR mil ... ... ... ... ... ... ...   289 292 341 552 567                  
Treasury Stock EUR mil ... ... ... ...         0 0 0 0 0                  
Equity Before Minority Interest EUR mil ... ... ... ...         239 214 233 425 415                  
Minority Interest EUR mil ... ... ... ...         0 0 0 0 0                  
Equity EUR mil ... ... ... ...         239 214 233 425 415                  
growth rates                                            
Total Asset Growth % ... ... ... ... ...       147 17.5 22.3 25.5 45.8                  
Shareholders' Equity Growth % ... ... ... ... ...       156 -10.5 8.78 82.6 -2.29                  
Net Debt Growth % ... ... ... ... ...       -59.9 -228 20.1 -350 -47.4                  
Total Debt Growth % ... ... ... ... ... ... ... ... ... 1,724 68.2 -74.4 518                  
ratios                                            
Total Debt EUR mil ... ... ... ...         4.86 88.7 149 38.2 236                  
Net Debt EUR mil ... ... ... ...         -23.4 29.9 36.0 -90.0 -47.4                  
Working Capital EUR mil ... ... ... ...         37.4 39.3 52.0 59.9 46.4                  
Capital Employed EUR mil ... ... ... ...         240 254 269 343 397                  
Net Debt/Equity % ... ... ... ...         -9.80 14.0 15.5 -21.2 -11.4                  
Current Ratio ... ... ... ...         2.30 2.58 3.53 3.41 3.49                  
Quick Ratio ... ... ... ... ... ... ...   1.18 1.53 2.34 2.12 2.51                  
cash flow Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
cash flow                                            
Net Profit EUR mil ... ... ... ...         -21.4 -33.6 -36.3 -16.8 -74.2                  
Depreciation EUR mil ... ... ... ...         2.49 3.62 14.9 5.82 11.4                  
Non-Cash Items EUR mil ... ... ... ...         -1.91 1.86 -0.302 6.82 24.0                  
Change in Working Capital EUR mil ... ... ... ...         -9.08 0.379 -14.7 -1.24 28.5                  
Total Cash From Operations EUR mil ... ... ... ...         -25.3 -18.2 -36.4 4.88 5.29                  
                                               
Capital Expenditures EUR mil ... ... ... ... ... ... ...   -9.62 -11.9 -14.7 -53.3 -43.2                  
Net Change in LT Investment EUR mil ... ... ... ...         0 -0.010 0 13.1 -10.3                  
Net Cash From Acquisitions EUR mil ... ... ... ... ... ... ...   1.26 -4.78 0 0 -31.2                  
Other Investing Activities EUR mil ... ... ... ...         7.50 -21.9 -18.7 0 0.303                  
Total Cash From Investing EUR mil ... ... ... ...         -0.858 -38.6 -33.4 -40.3 -84.3                  
                                               
Dividends Paid EUR mil ... ... ... ...         0 0 0 0 0                  
Issuance Of Shares EUR mil ... ... ... ...         0 0 49.1 63.4 0                  
Issuance Of Debt EUR mil ... ... ... ...         -1.10 72.4 55.0 -12.5 224                  
Other Financing Activities EUR mil ... ... ... ...         -0.322 -2.22 3.97 12.4 12.2                  
Total Cash From Financing EUR mil ... ... ... ...         -1.42 70.2 108 63.2 236                  
                                               
Effect of FX Rates EUR mil ... ... ... ...         0 0 0 0 0                  
Net Change In Cash EUR mil ... ... ... ...         -27.6 13.4 38.3 27.8 157                  
ratios                                            
Days Sales Outstanding days ... ... ... ...         26.4 14.9 13.9 11.3 9.61                  
Days Sales Of Inventory days ... ... ... ...         64.5 35.9 36.7 39.6 44.4                  
Days Payable Outstanding days ... ... ... ...         37.2 21.6 20.3 25.0 35.9                  
Cash Conversion Cycle days ... ... ... ...         53.7 29.2 30.3 25.9 18.1                  
Cash Earnings EUR mil ... ... ... ...         -18.9 -30.0 -21.4 -10.9 -62.8                  
Free Cash Flow EUR mil ... ... ... ...         -26.1 -56.8 -69.8 -35.4 -79.0                  
Capital Expenditures (As % of Sales) % ... ... ... ...         3.39 2.20 2.10 5.51 4.07                  
other ratios Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
                                             
Employees ... ... ... ...         483 843 1,011 1,220 1,569 ... ... ... ... ... ... ... ... ...
Cost Per Employee USD per month ... ... ... ...         3,875 4,629 5,051 5,349 7,608 ... ... ... ... ... ... ... ... ...
Cost Per Employee (Local Currency) EUR per month ... ... ... ...         3,451 3,952 4,457 4,571 6,354 ... ... ... ... ... ... ... ... ...
Operating Cost (As % of Sales) % ... ... ... ...         28.1 23.8 24.5 22.8 31.3 ... ... ... ... ... ... ... ... ...
Research & Development (As % of Sales) % ... ... ... ...         0 0 0 0 0 ... ... ... ... ... ... ... ... ...
Staff Cost (As % of Sales) % ... ... ... ...         7.04 7.41 7.71 6.91 11.3 ... ... ... ... ... ... ... ... ...
Effective Tax Rate % ... ... ... ...         0.210 2.84 14.0 -5.27 4.75                  
Total Revenue Growth (5-year average) % ... ... ... ... ... ... ... ... ... 57.7 52.6 50.5 43.0                  
Total Revenue Growth (10-year average) % ... ... ... ... ... ... ... ... ... ... ... ... ... ...                
Customers mil ... ... ...           2.70 3.50 4.70 6.30 7.90                  
valuation Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
                                             
Market Capitalisation USD mil ... ... ... ... ... ... ...   670 519 638 3,203 2,304                  
Enterprise Value (EV) USD mil ... ... ... ... ... ... ...   642 553 678 3,093 2,250                  
Number Of Shares mil ... ... ... ... ... ... ...   9.50 12.0 13.1 14.4 17.9                  
Share Price EUR ... ... ... ... ... ... ...   46.4 37.6 43.5 148 113                  
EV/EBITDA ... ... ... ... ... ... ...   -47.1 -30.3 -32.2 174 -48.5                  
Price/Earnings (P/E) ... ... ... ... ... ... ...   -20.6 -13.5 -15.6 -127 -27.3                  
Price/Cash Earnings (P/CE) ... ... ... ... ... ... ...   -23.3 -15.1 -26.5 -195 -32.3                  
P/FCF ... ... ... ... ... ... ...   -16.8 -7.98 -8.14 -60.2 -25.6                  
Price/Book Value (P/BV) ... ... ... ... ... ... ...   1.84 2.12 2.44 5.01 4.88                  
Dividend Yield % ... ... ... ... ... ... ...   0 0 0 0 0                  
Free Cash Flow Yield % ... ... ... ... ... ... ...   -4.38 -12.8 -12.4 -1.29 -4.11                  
Earnings Per Share (EPS) EUR ... ... ... ... ... ... ...   -2.25 -2.79 -2.78 -1.17 -4.15                  
Cash Earnings Per Share EUR ... ... ... ... ... ... ...   -1.99 -2.49 -1.64 -0.761 -3.51                  
Free Cash Flow Per Share EUR ... ... ... ... ... ... ...   -2.75 -4.71 -5.35 -2.46 -4.42                  
Book Value Per Share EUR ... ... ... ... ... ... ...   25.2 17.8 17.8 29.6 23.2                  
Dividend Per Share EUR ... ... ... ... ... ... ...   0 0 0 0 0                  
EV/Sales ... ... ... ... ... ... ...   2.01 0.875 0.854 2.73 1.77                  
EV/EBIT ... ... ... ... ... ... ...   -29.8 -16.4 -17.9 -3,053 -28.6                  
EV/Free Cash Flow ... ... ... ... ... ... ...   -21.9 -8.32 -8.57 -74.7 -23.8                  
EV/Capital Employed ... ... ... ... ... ... ...   2.23 1.90 2.25 7.39 4.99                  
Earnings Per Share Growth % ... ... ... ... ... ... ... ... -26.9 24.0 -0.358 -57.9 255                  
Cash Earnings Per Share Growth % ... ... ... ... ... ... ... ... -32.7 25.3 -34.2 -53.5 361                  
Book Value Per Share Growth % ... ... ... ... ... ... ... ... 61.7 -29.4 0.302 65.9 -21.4                  
Market Value per Customer USD ... ... ... ... ... ... ...   248 148 136 508 292                  
Sales per Customer USD ... ... ... ...         118 181 169 180 161                  
EBITDA per Customer USD ... ... ... ...         -5.05 -5.21 -4.48 2.82 -5.87                  
Net Profit per Customer USD ... ... ... ...         -8.88 -11.2 -8.75 -3.11 -11.2                  
clients & arpu Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
                                             
Customers mil ... ... ...           2.70 3.50 4.70 6.30 7.90                  
ARPU from Total Business EUR per month ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...      
Basket Size (USD) USD ... ... ... ... ... ... ...   64.9 85.5 75.9 77.7 73.2 ... ... ... ... ... ... ... ... ...
Repeat Order Rate % ... ... ... ... ... ... ...   76.0 81.0 82.0 82.0 82.0 ... ... ... ... ... ... ... ... ...
Site Visits mil ... ... ... ... ... ... ...   71.5 93.1 134 208 ... ... ... ... ... ... ... ... ... ...

Get all company financials in excel:

Download Sample   $19.99

Shop Apotheke Europe's price/earnings (P/E) rose 55.9% yoy to -12.0 in 2022

By Helgi Library - May 22, 2023

Shop Apotheke Europe stock traded at EUR 41.8 per share at the end 2022 translating into a market capitalization of USD 885 mil. Since the end of 2017, stock has depreciated by 9.88% representing an annual average growth of -2.06%. In absolute terms, th...

Shop Apotheke Europe's Net Margin rose 27.2% yoy to -5.10% in 2022

By Helgi Library - May 22, 2023

Shop Apotheke Europe made a net profit of EUR -62.6 mil with revenues of EUR 1,229 mil in 2022, up by 15.6% and up by 15.9%, respectively, compared to the previous year. This translates into a net margin of -5.10%. Historically, between 2013 and 2022, ...

Shop Apotheke Europe's Net Margin rose 27.2% yoy to -5.10% in 2022

By Helgi Library - May 22, 2023

Shop Apotheke Europe made a net profit of EUR -62.6 mil with revenues of EUR 1,229 mil in 2022, up by 15.6% and up by 15.9%, respectively, compared to the previous year. This translates into a net margin of -5.10%. Historically, between 2013 and 2022, ...

Shop Apotheke Europe's ROCE rose 26.4% yoy to -14.8% in 2022

By Helgi Library - May 22, 2023

Shop Apotheke Europe made a net profit of EUR -62.6 mil in 2022, up 15.6% compared to the previous year. Historically, between 2013 and 2022, the company's net profit reached a high of EUR -2.83 mil in 2013 and a low of EUR -74.2 mil in 2021. The result i...

Shop Apotheke Europe's ROCE rose 26.4% yoy to -14.8% in 2022

By Helgi Library - May 22, 2023

Shop Apotheke Europe made a net profit of EUR -62.6 mil in 2022, up 15.6% compared to the previous year. Historically, between 2013 and 2022, the company's net profit reached a high of EUR -2.83 mil in 2013 and a low of EUR -74.2 mil in 2021. The result i...

Shop Apotheke Europe's Net Profit per Customer rose 29.8% yoy to USD -7.90 in 2022

By Helgi Library - May 22, 2023

Shop Apotheke Europe made a net profit of EUR -62.6 mil with revenues of EUR 1,229 mil in 2022, up by 15.6% and up by 15.9%, respectively, compared to the previous year. This translates into a net margin of -5.10%. On the operating level, EBITDA reached EUR...

Shop Apotheke Europe's Net Profit per Customer rose 29.8% yoy to USD -7.90 in 2022

By Helgi Library - May 22, 2023

Shop Apotheke Europe made a net profit of EUR -62.6 mil with revenues of EUR 1,229 mil in 2022, up by 15.6% and up by 15.9%, respectively, compared to the previous year. This translates into a net margin of -5.10%. On the operating level, EBITDA reached EUR...

Shop Apotheke Europe's Capital Expenditures fell 73.8% yoy to EUR 75.0 mil in 2022

By Helgi Library - May 22, 2023

Shop Apotheke Europe invested a total of EUR 75.0 mil in 2022, up 73.8% compared to the previous year. Historically, between 2016 - 2022, the company's investments stood at a high of EUR 75.0 mil in 2022 and a low of EUR 3.89 mil in 2016. ...

Shop Apotheke Europe's Capital Expenditures fell 73.8% yoy to EUR 75.0 mil in 2022

By Helgi Library - May 22, 2023

Shop Apotheke Europe invested a total of EUR 75.0 mil in 2022, up 73.8% compared to the previous year. Historically, between 2016 - 2022, the company's investments stood at a high of EUR 75.0 mil in 2022 and a low of EUR 3.89 mil in 2016. ...

Shop Apotheke Europe's Net Debt/EBITDA fell 644% yoy to -6.66 in 2022

By Helgi Library - May 22, 2023

Shop Apotheke Europe's net debt stood at EUR 92.9 mil and accounted for 26.3% of equity at the end of 2022. The ratio is up 37.7 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 26.3% in 2022 and a l...

More News

Shop Apotheke Europe NV is a Netherlands-based Company that retails pharmaceutical products online. The Company focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The Company owns and operates online pharmacies in eight European countries such as in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.

Shop Apotheke Europe Logo

Finance

Shop Apotheke Europe has been growing its sales by 13.1% a year on average in the last 5 years. EBITDA has grown on average by 20.5% a year during that time to total of EUR 275 mil in 2030, or 6.72% of sales. That’s compared to 6.05% average margin seen in last five years.

The company netted EUR 152 mil in 2030 implying ROE of 17.7% and ROCE of 15.1%. Again, the average figures were 18.6% and 13.3%, respectively when looking at the previous 5 years.

Shop Apotheke Europe’s net debt amounted to EUR 97.4 mil at the end of 2030, or 10.4% of equity. When compared to EBITDA, net debt was 0.354x, down when compared to average of 1.05x seen in the last 5 years.

Valuation

Shop Apotheke Europe stock traded at EUR 91.9 per share at the end of 2030 resulting in a market capitalization of USD 1,947 mil. Over the previous five years, stock price grew by 0% or 0% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 6.38x and price to earnings (PE) of 10.9x as of 2030.